The global Cartilage Repair/ Cartilage RegenerationMarketwas valued at USD 414.5 million in 2016 and is projected to reach USD 1288.47 million by 2025, growing at a CAGR of 13.43% from 2017 to 2025.
Knee Injuries and cartilage damage are becoming more prevalent with increasing geriatric population coupled with popularity of sports and athletics. The market for the same is thus expected to grow during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growth in Obese Population
1.2 Rising Incidence of Sport Injuries
2. Market Restraints
2.1 High Cost of Therapy
2.2 Unfavorable Reimbursement Scenario
Market Segmentation:
1. Global Cartilage Repair/ Cartilage Regeneration Market, by Application:
1.1 Hyaline Cartilage Repair and Regeneration
1.2 Fibrocartilage Repair and Regeneration
2. Global Cartilage Repair/ Cartilage Regeneration Market, by Treatment Modality:
2.1 Cell-Based Approaches
2.2 Chondrocyte Transplantation
2.3 Growth Factor Technology
2.4 Stem Cells
2.5 Non-Cell-Based Approaches
2.6 Tissue Scaffolds
2.7 Cell-Free Composites
3. Global Cartilage Repair/ Cartilage Regeneration Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Zimmer Biomet Holdings, Inc.
2. DepuySynthes (Johnson & Johnson Company)
3. Vericel Corporation
4. Smith & Nephew PLC
5. Osiris Therapeutics, Inc.
6. Arthrex, Inc.
7. RTI Surgical
8. ConmedLinvatec
9. Anika Therapeutics S. R. L.
10. B. Braun Melsungen AG
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cartilage Repair/ Cartilage RegenerationMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CARTILAGE REPAIR/ CARTILAGE REGENERATIONMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CARTILAGE REPAIR/ CARTILAGE REGENERATIONMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CARTILAGE REPAIR/ CARTILAGE REGENERATION MARKET, BY APPLICATION
5.1 Hyaline Cartilage Repair and Regeneration
5.2 Fibrocartilage Repair and Regeneration
6 GLOBAL CARTILAGE REPAIR/ CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY
6.1 Cell-Based Approaches
6.2 Chondrocyte Transplantation
6.3 Growth Factor Technology
6.4 Stem Cells
6.5 Non-Cell-Based Approaches
6.6 Tissue Scaffolds
6.7 Cell-Free Composites
7 GLOBAL CARTILAGE REPAIR/ CARTILAGE REGENERATIONMARKET, BY GEOGRAPHY
7.1 Overview
7.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
8 GLOBAL CARTILAGE REPAIR/ CARTILAGE REGENERATIONMARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Zimmer Biomet Holdings, Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 DepuySynthes (Johnson & Johnson Company)
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Vericel Corporation
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Smith & Nephew PLC
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Osiris Therapeutics, Inc.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Arthrex, Inc.
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 RTI Surgical
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 ConmedLinvatec
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 LAnika Therapeutics S. R. L.
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 B. Braun Melsungen AG
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Reports